Vireo Growth (VREOF) Assets Average (2021 - 2026)
Vireo Growth's (VREOF) quarterly Assets Average came in at $873.0 million in Q1 2026, up 214.08% year-on-year from $278.0 million in Q1 2025, and up 16.7% quarter-over-quarter from $748.1 million in Q4 2025.
Vireo Growth (VREOF) Assets Average (2021 - 2026) Analysis & Trends
Vireo Growth has disclosed Assets Average across 6 years of filings, most recently posting $873.0 million for Q1 2026.
- Assets Average for Q1 2026 came in at $873.0 million, up 214.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $873.0 million (up 214.08% YoY), and the FY2025 annual result was $548.0 million, up 137.18% from the prior year.
- Assets Average came in at $873.0 million for Q1 2026 at Vireo Growth, up from $748.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $873.0 million in Q1 2026 to a low of $158.9 million in Q1 2023.
- The 5-year median for Assets Average is $187.1 million (2024), against an average of $304.7 million.
- Across the five-year window, Assets Average retreated 3.02% in 2023 and soared 244.42% in 2025, its largest moves.
- Vireo Growth's Assets Average stood at $166.2 million in 2022, then climbed by 6.75% to $177.5 million in 2023, then surged by 33.19% to $236.4 million in 2024, then surged by 216.48% to $748.1 million in 2025, then gained by 16.7% to $873.0 million in 2026.
- The last three Assets Average figures came in at $873.0 million (Q1 2026), $748.1 million (Q4 2025), and $669.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 873.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 873.00 Mn |
| Dec 31, 2025 | 748.06 Mn |
| Sep 30, 2025 | 669.13 Mn |
| Jun 30, 2025 | 468.19 Mn |
| Mar 31, 2025 | 277.95 Mn |
| Dec 31, 2024 | 236.37 Mn |
| Sep 30, 2024 | 194.27 Mn |
| Jun 30, 2024 | 192.78 Mn |
| Mar 31, 2024 | 187.07 Mn |
| Dec 31, 2023 | 177.47 Mn |
| Sep 30, 2023 | 168.81 Mn |
| Jun 30, 2023 | 162.29 Mn |
| Mar 31, 2023 | 158.89 Mn |
| Dec 31, 2022 | 166.24 Mn |
| Sep 30, 2022 | 171.07 Mn |
| Jun 30, 2022 | 164.78 Mn |
| Mar 31, 2022 | 163.85 Mn |
| Dec 31, 2021 | 165.57 Mn |
| Sep 30, 2021 | 138.42 Mn |
| Jun 30, 2021 | 118.06 Mn |